Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11. - Bertuccioli A; Sisti D; Lazzerini N; Palazzi CM; Zonzini GB; Ragazzini M; Belli A (Frontiers in medicine, 2025)